Azithromycin use is associated with reduced maternal sepsis

1. In this randomized controlled trial, a single dose of azithromycin reduced the risk of maternal sepsis or death among women in labor planning a vaginal birth as compared to a placebo. 2. Azithromycin use was not associated with a decreased risk of stillbirth, neonatal death, or neonatal sepsis. Evidence Rating Level: 1 (Excellent) Study

Related Keywords

, Minute Medicine Inc , Rating Level , Relative Risk , Confidence Interval , Azithromycin , Birth , Infectious Disease , Maternal Mortality , Maternal Sepsis , Neonatal Mortality , Neonatal Sepsis , Neonatology , Obstetrics , Prophylaxis , Public Health , Stillbirth , Vaginal Birth ,